ask="7.25"
ask_size="100"
average_daily_volume="203695"
bid="N/A"
bid_size="N/A"
book_value="1.38"
change="-0.30"
change_from_200_day_moving_average="-1.14"
change_from_50_day_moving_average="-0.24"
change_from_52_week_high="-3.25"
change_From_52_week_low="0.85"
change_in_percent="-5.56%"
close="5.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.61"
ebitda="-55.83M"
eps_estimate_current_year="-1.25"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.09"
ex_dividend_date="N/A"
float_shares="42874000"
high="5.40"
high_52_weeks="8.35"
last_trade_date="2/1/2017"
last_trade_price="5.10"
last_trade_size="4281"
last_trade_time="4:00pm"
low="5.10"
low_52_weeks="4.25"
market_capitalization="295.49M"
moving_average_200_day="6.24"
moving_average_50_day="5.34"
name="Sorrento Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.00"
open="5.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-18.21%"
percent_change_from_50_day_moving_average="-4.56%"
percent_change_from_52_week_high="-38.92%"
percent_change_from_52_week_low="+20.00%"
previous_close="5.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.90"
price_per_sales="57.20"
revenue="5.47M"
shares_outstanding="57939000"
short_ratio="18.60"
stock_exchange="NCM"
symbol="SRNE"
volume="95589"
weeks_range_52="4.25 - 8.35"
